Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Risk/reward changed a lot on $AEHR from 21 after last quarter on that massive squeeze to 12s recently - main key imho is diversification away from $ON being an 85% customer and sev good secular irons in the fire, along w/ seeing the worst (likely) of the EV cyclical pressure
$AEHR +17% pre market
Upside: $AEHR +11% (earnings, guidance) $ALLK +7.7% (top-line Phase 1 results of Intravenous AK006 in patients with CSU expected in early 1Q25) $UBER +5.1% (lower following TSLA โWe Robotโ event) $FROG +4.0% (said to attract early takeover interest; not in talks with PE orโฆ
Aehr Test Systems reported better-than-expected Q1 earnings, with revenue of $13.1 million and non-GAAP EPS of $0.07, both surpassing consensus estimates. The company reaffirmed its fiscal 2025 guidance and noted bookings of $16.8 million. Despite a decrease in net revenue from $20.6 million in Q1 FY24, the stock saw a significant rise, climbing 13.66% pre-market to $15.14. The CEO highlighted a strong start to the fiscal year, with new operations in GaN, AI, and HDD sectors expected to contribute positively. GAAP EPS was reported at $0.02.
